ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection
- RxCUI
- 1659283
- RxNorm name
- ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection
- Display name
- ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection
- Full name
- ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 9b73979c-c95a-4433-0a9d-f9cea3cb557f | 2026-06-04 | Warnings, Adverse reactions | 1659283 |
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 40d48c5d-650e-461b-a67b-7e65772d1b92 | 2026-05-04 | Warnings, Adverse reactions | 1659283 |
| Ceftazidime | CEFTAZIDIME | WG Critical Care, LLC | bcc81df2-20e3-4738-bfcf-301da883c1d9 | 2023-09-11 | Warnings, Adverse reactions | 1659283 |
| Ceftazidime | CEFTAZIDIME | Sagent Pharmaceuticals | 112c5457-8d71-49f5-b531-9761d7d38c93 | 2020-10-05 | Warnings, Adverse reactions | 1659283 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9b73979c-c95a-4433-0a9d-f9cea3cb557f | ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection | SY | 29 | TAZICEF ® brand of ceftazidime for injection, USP | 20211101 |
| 9b73979c-c95a-4433-0a9d-f9cea3cb557f | cefTAZidime 1 GM Injection | PSN | 29 | TAZICEF ® brand of ceftazidime for injection, USP | 20211101 |
| 9b73979c-c95a-4433-0a9d-f9cea3cb557f | ceftazidime 1000 MG Injection | SCD | 29 | TAZICEF ® brand of ceftazidime for injection, USP | 20211101 |
| 9b73979c-c95a-4433-0a9d-f9cea3cb557f | ceftazidime 1 GM Injection | SY | 29 | TAZICEF ® brand of ceftazidime for injection, USP | 20211101 |
| 40d48c5d-650e-461b-a67b-7e65772d1b92 | cefTAZidime 1 GM Injection | PSN | 16 | 20260504 | |
| 40d48c5d-650e-461b-a67b-7e65772d1b92 | ceftazidime 1000 MG Injection | SCD | 16 | 20260504 | |
| 40d48c5d-650e-461b-a67b-7e65772d1b92 | ceftazidime 1 GM Injection | SY | 16 | 20260504 | |
| 40d48c5d-650e-461b-a67b-7e65772d1b92 | ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection | SY | 16 | 20260504 | |
| 112c5457-8d71-49f5-b531-9761d7d38c93 | cefTAZidime 1 GM Injection | PSN | 11 | Ceftazidime for Injection, USP | 20201005 |
| 112c5457-8d71-49f5-b531-9761d7d38c93 | ceftazidime 1 GM Injection | SY | 11 | Ceftazidime for Injection, USP | 20201005 |
| 112c5457-8d71-49f5-b531-9761d7d38c93 | ceftazidime 1000 MG Injection | SCD | 11 | Ceftazidime for Injection, USP | 20201005 |
| 112c5457-8d71-49f5-b531-9761d7d38c93 | ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection | SY | 11 | Ceftazidime for Injection, USP | 20201005 |
| bcc81df2-20e3-4738-bfcf-301da883c1d9 | ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection | SY | 10 | Ceftazidime for Injection | 20230911 |
| bcc81df2-20e3-4738-bfcf-301da883c1d9 | ceftazidime 1000 MG Injection | SCD | 10 | Ceftazidime for Injection | 20230911 |
| bcc81df2-20e3-4738-bfcf-301da883c1d9 | ceftazidime 1 GM Injection | SY | 10 | Ceftazidime for Injection | 20230911 |
| bcc81df2-20e3-4738-bfcf-301da883c1d9 | cefTAZidime 1 GM Injection | PSN | 10 | Ceftazidime for Injection | 20230911 |
| 78982c98-7866-49f1-989f-a289c4242358 | cefTAZidime 1 GM Injection | PSN | 9 | FORTAZ ® (ceftazidime for injection) | 20170728 |
| 78982c98-7866-49f1-989f-a289c4242358 | ceftazidime 1 GM Injection | SY | 9 | FORTAZ ® (ceftazidime for injection) | 20170728 |
| 78982c98-7866-49f1-989f-a289c4242358 | ceftazidime 1000 MG Injection | SCD | 9 | FORTAZ ® (ceftazidime for injection) | 20170728 |
| 78982c98-7866-49f1-989f-a289c4242358 | ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection | SY | 9 | FORTAZ ® (ceftazidime for injection) | 20170728 |